Report Details:
15 Companies Covered
90 Pages
Drug Discovery Informatics Market to grow 9.4% CAGR during the Forecast Period 2025 to 2035
Market Research Future (MRFR) has published a cooked research report on the “Global Drug Discovery Informatics Market” that contains information from 2019 to 2035. The Drug Discovery Informatics Market is estimated to register a CAGR of 9.4% during the forecast period of 2025 to 2035.
MRFR recognizes the following companies as the key players in the Global Drug Discovery Informatics Market — Thermo Fisher Scientific (US), PerkinElmer (US), Schrodinger (US), Cresset (GB), Certara (US), Bioinformatics Solutions (CA), Dotmatics (GB), Accelrys (US), and ChemAxon (HU).
Market Highlights
The Global Drug Discovery Informatics Market is accounted for to register a CAGR of 9.4% during the forecast period and is estimated to reach USD 10.21 Billion by 2035.
The market growth is driven by the increasing adoption of Artificial Intelligence (AI), data analytics, and cloud computing in pharmaceutical research and development. Drug discovery informatics enables researchers to efficiently manage and analyze large datasets, accelerating target identification, lead optimization, and clinical trial processes.
The integration of AI and machine learning is transforming the drug discovery landscape by enabling predictive modeling, molecule screening, and simulation of drug interactions. Moreover, the rising demand for personalized medicine is driving the need for advanced informatics platforms capable of analyzing genetic and molecular data to support tailored therapeutic approaches.
In addition, collaborative research ecosystems between pharmaceutical companies and technology providers are expanding, fostering innovation and data-driven decision-making. Regulatory support and government funding, particularly in biomedical research and digital infrastructure, are further stimulating market growth.
Major players such as Thermo Fisher Scientific, PerkinElmer, and Schrodinger are actively investing in AI-driven platforms and cloud-based collaboration tools to enhance efficiency and enable real-time data sharing among global research teams. These initiatives are contributing to the continued evolution and expansion of the Drug Discovery Informatics industry.
Segment Analysis
The Global Drug Discovery Informatics Market has been segmented based on Product, Mode, Service, and Region.
- By Product, the market is divided into Discovery Informatics and Development Informatics. The Discovery Informatics segment held the largest share in 2024 due to its essential role in early-stage research, while Development Informatics is projected to be the fastest-growing segment, driven by increasing demand for efficient data management during clinical trials and regulatory processes.
- By Mode, the market is segmented into In-House Informatics and Outsourced Informatics. The In-House segment dominates due to organizations’ preference for internal data control and enhanced security, whereas Outsourced Informatics is gaining traction owing to cost-efficiency and access to specialized expertise.
- By Service, the market includes Clinical Trial Data Management, Molecular Modeling, Sequencing and Target Data Analysis, and Docking. Among these, Clinical Trial Data Management held the largest share in 2024, while Molecular Modeling is the fastest-growing service due to its increasing use in simulating molecular interactions and accelerating lead discovery.
Region Analysis
By Region, the Drug Discovery Informatics Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World.
- North America dominates the market, accounting for nearly 45% of the global share, driven by substantial investments in biotechnology, advanced healthcare infrastructure, and the presence of key market players. The U.S. remains the largest contributor, supported by ongoing research funding and technological innovation.
- Europe follows, holding about 30% of the market share, led by countries such as Germany and the UK, where regulatory frameworks and research collaborations support digital transformation in pharmaceutical development.
- The Asia-Pacific region is the fastest-growing market, supported by increasing government investments in healthcare infrastructure, growing clinical trial activity, and the rapid expansion of pharmaceutical R&D in China and India.
- The Middle East and Africa region holds smaller yet emerging opportunities, driven by improving healthcare systems and rising R&D investments in countries like UAE and South Africa.
Key Findings of the Study
- The Global Drug Discovery Informatics Market is expected to reach USD 10.21 Billion by 2035, at a CAGR of 9.4% during the forecast period.
- North America accounted for the largest market share, while Asia-Pacific emerged as the fastest-growing region.
- Based on Product, Discovery Informatics dominated the market in 2024, while Development Informatics is expected to grow at the highest CAGR.
- Based on Mode, In-House Informatics held the largest share, whereas Outsourced Informatics is rapidly expanding.
- Based on Service, Clinical Trial Data Management dominated, while Molecular Modeling is anticipated to be the fastest-growing segment.
- Key market players include Thermo Fisher Scientific, PerkinElmer, Schrodinger, Cresset, Certara, Bioinformatics Solutions, Dotmatics, Accelrys, and ChemAxon.